Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine and Magnesium for Neuropathic Pain
NCT02467517Phase 2Unknown
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Nov 2015
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ketamine in neuropathic pain (3 arms), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Numerical Rating Scale for Pain at 5 weeks. Status: unknown.
02
Drugs
ketamine
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT02467517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02467517.